Quoin Pharmaceuticals, Ltd. American Depositary Shares Share Price
QNRXQuoin Pharmaceuticals, Ltd. American Depositary Shares Stock Performance
Open $5.79 | Prev. Close $5.74 | Circuit Range N/A |
Day Range $5.79 - $6.13 | Year Range $5.21 - $39.00 | Volume 757 |
Average Traded $5.96 |
Quoin Pharmaceuticals, Ltd. American Depositary Shares Share Price Chart
About Quoin Pharmaceuticals, Ltd. American Depositary Shares
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Quoin Pharmaceuticals, Ltd. American Depositary Shares Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Apr-26 | $5.80 | $5.74 | +6.60% |
28-Apr-26 | $5.51 | $5.38 | -3.41% |
24-Apr-26 | $5.43 | $5.57 | -4.13% |
20-Apr-26 | $6.33 | $5.81 | -9.64% |
17-Apr-26 | $6.43 | $6.43 | +0.39% |
16-Apr-26 | $6.41 | $6.41 | -1.54% |
14-Apr-26 | $6.50 | $6.50 | +11.39% |